Floatz logo

Pmpbb3

Neuroinflammation

Chang Gung Memorial HospitalradiopharmaceuticalPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Neuroinflammation cohort.

Asset / SponsorPhaseRating
Dfn-15
Stony Brook University
Phase 4BB
Ashwagandha
Hasanuddin University
Phase 2B
Risperdal
Hasanuddin University
Phase 2B
Rvp-001
Reveal Pharmaceuticals Inc.
Phase 2B
HUMAN IMMUNOGLOBULINS
National Institute of Neurological Disorders and Stroke (NINDS)
Phase 2CCC
THK-5351
Chang Gung Memorial Hospital
Phase 2CCC
BLOOD, WHOLE
Vrije Universiteit Brussel
D
Arestin
University of Cincinnati
Phase 1NR

Same molecule, other indications

Pmpbb3 is also rated in:

cognitive disorderDormant
CCC
Indicative ·
53 / 100
View asset →
Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal DementiaDormant
CCC
Indicative ·
53 / 100
View asset →
Alzheimer diseaseDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →